On Open-Label Study in Participants With Systemic Lupus Erythematosus
Status:
Terminated
Trial end date:
2015-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this SLE study is to evaluate the long-term safety and efficacy of LY2127399
in eligible SLE participants who have completed the core studies (NCT01196091) (NCT01205438).